Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pyridostigmine (Mestinon) on muscle strength in Myasthenia Gravis
2017-002599-15Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myasthenia gravis (MG) comparing Pyridostigmine (Mestinon) with Placebo (2 arms). Primary endpoint: Change on clinical rating scales. Started Jul 2017; status: completed.
02
Drugs
pyridostigmine
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on 2017-002599-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002599-15.